290 related articles for article (PubMed ID: 36220808)
21. Evaluation of clinicians' knowledge, attitudes, and planned behaviors related to an intervention to improve acute respiratory infection management.
Hruza HR; Velasquez T; Madaras-Kelly KJ; Fleming-Dutra KE; Samore MH; Butler JM
Infect Control Hosp Epidemiol; 2020 Jun; 41(6):672-679. PubMed ID: 32178749
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists.
Alcalay RN; Kehoe C; Shorr E; Battista R; Hall A; Simuni T; Marder K; Wills AM; Naito A; Beck JC; Schwarzschild MA; Nance M
Genet Med; 2020 Mar; 22(3):574-580. PubMed ID: 31680121
[TBL] [Abstract][Full Text] [Related]
23. "Would you test your children without their consent?" and other sticky dilemmas in the field of cancer genetic testing.
Brierley KL; Bonadies DC; Moyer A; Matloff ET
Fam Cancer; 2014 Sep; 13(3):345-50. PubMed ID: 24804937
[TBL] [Abstract][Full Text] [Related]
24. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians.
Lowstuter KJ; Sand S; Blazer KR; MacDonald DJ; Banks KC; Lee CA; Schwerin BU; Juarez M; Uman GC; Weitzel JN
Genet Med; 2008 Sep; 10(9):691-8. PubMed ID: 18978681
[TBL] [Abstract][Full Text] [Related]
25. Primary care clinicians' attitudes towards point-of-care blood testing: a systematic review of qualitative studies.
Jones CH; Howick J; Roberts NW; Price CP; Heneghan C; Plüddemann A; Thompson M
BMC Fam Pract; 2013 Aug; 14():117. PubMed ID: 23945264
[TBL] [Abstract][Full Text] [Related]
26. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.
Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC
Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822
[TBL] [Abstract][Full Text] [Related]
27. Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers.
Forsner T; Hansson J; Brommels M; Wistedt AA; Forsell Y
BMC Psychiatry; 2010 Jan; 10():8. PubMed ID: 20089141
[TBL] [Abstract][Full Text] [Related]
28. Genetic discrimination: the clinician perspective.
Nedelcu R; Blazer KR; Schwerin BU; Gambol P; Mantha P; Uman GC; Weitzel JN
Clin Genet; 2004 Oct; 66(4):311-7. PubMed ID: 15355433
[TBL] [Abstract][Full Text] [Related]
29. Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.
Shkedi-Rafid S; Ofer-Bialer G; Meiner V; Calderon-Margalit R
Public Health Genomics; 2013; 16(4):174-83. PubMed ID: 23816973
[TBL] [Abstract][Full Text] [Related]
30. Editorial: Polygenic scores in child and adolescent psychiatry - strengths, weaknesses, opportunities and threats.
Ronald A
J Child Psychol Psychiatry; 2020 May; 61(5):519-521. PubMed ID: 32304105
[TBL] [Abstract][Full Text] [Related]
31. [Attitudes towards predictive genetic testing for Alzheimer's disease].
Illes F; Bernhardt T; Prell K; Rietz C; Rudinger G; Frölich L; Maier W; Rietschel M
Z Gerontol Geriatr; 2006 Jun; 39(3):233-9. PubMed ID: 16794889
[TBL] [Abstract][Full Text] [Related]
32. Genomic medicine and risk prediction across the disease spectrum.
Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners.
Undurraga J; Bórquez-Infante I; Crossley NA; Prieto ML; Repetto GM
Front Pharmacol; 2021; 12():657985. PubMed ID: 33935777
[TBL] [Abstract][Full Text] [Related]
34. Self-guided management of exome and whole-genome sequencing results: changing the results return model.
Yu JH; Jamal SM; Tabor HK; Bamshad MJ
Genet Med; 2013 Sep; 15(9):684-90. PubMed ID: 23619276
[TBL] [Abstract][Full Text] [Related]
35. Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.
Roberts JS; Uhlmann WR
Prog Neurobiol; 2013 Nov; 110():89-101. PubMed ID: 23583530
[TBL] [Abstract][Full Text] [Related]
36. Preconception genome medicine: current state and future perspectives to improve infertility diagnosis and reproductive and health outcomes based on individual genomic data.
Capalbo A; Poli M; Riera-Escamilla A; Shukla V; Kudo Høffding M; Krausz C; Hoffmann ER; Simon C
Hum Reprod Update; 2021 Feb; 27(2):254-279. PubMed ID: 33197264
[TBL] [Abstract][Full Text] [Related]
37. Anticipating the Ethical Challenges of Psychiatric Genetic Testing.
Appelbaum PS; Benston S
Curr Psychiatry Rep; 2017 Jul; 19(7):39. PubMed ID: 28534296
[TBL] [Abstract][Full Text] [Related]
38. Genetic knowledge and attitudes of parents of children with congenital heart defects.
Fitzgerald-Butt SM; Klima J; Kelleher K; Chisolm D; McBride KL
Am J Med Genet A; 2014 Dec; 164A(12):3069-75. PubMed ID: 25256359
[TBL] [Abstract][Full Text] [Related]
39. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
40. Utility and Barriers to Clozapine Use: A Joint Study of Clinicians' Attitudes From Singapore and Hong Kong.
Zheng S; Lee J; Chan SKW
J Clin Psychiatry; 2022 May; 83(4):. PubMed ID: 35584194
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
